The Iliac/SFA/Popliteal Center

Filter Your Results




Experience With Atherectomy and DCBs

Ulrich Sunderdiek, MD, PhD

September 2017—The merits of a two-part approach in the SFA and popliteal artery.

Economic Analysis Supporting the Use of Drug-Eluting Technologies in the Femoropopliteal Artery

Konstantinos Katsanos, MSc, MD, PhD, EBIR

September 2017—These evolving modern therapies are showing promise in reducing health care costs while offering better outcomes.

Clinical Benefit of Long-Length Drug-Coated Balloons

Gunnar Tepe, MD

September 2017—The anatomic factors that make longer DCBs the ideal choice for treating longer, more difficult lesions.

Experience With Drug-Eluting Technologies in BTK Interventions

Hans van Overhagen, MD, PhD, EBIR

September 2017—Promising results for drug-eluting stent use in CLI patients with lesions below the knee.

New Technologies to Solve the Challenges of CLI

J.A. Mustapha, MD, and Fadi Saab, MD

September 2017—The unique features of this disease are finally being addressed with new devices.

The Impact of Swirling Flow in Treating Atherosclerosis in the Superficial Femoral Artery

Peter A. Gaines, MD

September 2017—Producing better results in primary stenting and the ideal complement to drug-coated balloons.

TINTIN Trial to Evaluate Combined Therapy With iVascular's Luminor DCB and iVolution BMS

September 29, 2017 -- iVascular, based in Barcelona, Spain, recently announced the initiation of the TINTIN trial, which is evaluating the combined therapy of the company…

Study Presented at CIRSE Explores Ocular Radiation Exposure and Role of Protective Eyewear

September 22, 2017 -- Gerard Goh, MBBS, FRANZCR, EBIR, and colleagues presented data at CIRSE 2017, the annual congress of the Cardiovascular and Interventional Radiological S…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.